Navigating SOE compliance: how to strengthen organic enforcement within your organisation

Published: 7-Oct-2025 Featured companies: NSF
Manufacturing Sustainability Regulatory

Part I of NSF’s webinar series explores strategies to meet rising regulatory demands, reduce fraud, and promote ethical practices

In Part I of the NSF webinar series, Navigating SOE Compliance, experts explored the importance of Strengthening Organic Enforcement (SOE) within organisations.

In an era where regulatory demands are on the rise, effective compliance strategies are essential not only for adherence but also for reducing fraud and promoting ethical practices.

Through real-world insights and practical guidance, this session highlights how companies can build stronger internal frameworks to ensure long-term trust, transparency, and sustainability in the organic supply chain.

To learn more or access future sessions in the Navigating SOE Compliance series, visit NSF’s website.

Featured companies

Founded in 1944, NSF’s mission is to protect and improve global human health. NSF, Pharmaceutical Services provides a comprehensive range of independent, third-party...
See more

You may also like

Manufacturing

Exploring Ireland’s thriving life sciences sector

Read more
NSF highlights its pivotal role in one of the world’s leading hubs for pharma and medical device manufacturing

Trending Articles

  1. Agility, scale and trust: the outsourcing model driving pharma forward Outsourcing in the pharmaceutical industry has long been viewed as a matter of convenience and a way to ease short-term capacity pressures or delay the decision to invest in costly new facilities. That framing no longer fits
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Human-machine symbiosis: why Industry 5.0 is the future of pharmaceutical manufacturing Industry 5.0 is reshaping pharmaceutical manufacturing by fostering human-machine collaboration, addressing workforce shortages and making advanced automation accessible to all through innovative models such as robot rental
  3. Rezon Bio launches as European biologics CDMO with mirrored sites in Poland New CDMO combines cost efficiency, digital innovation and EMA/FDA-audited facilities in Gdańsk and Warsaw to accelerate biologics development and commercialisation
  4. RION engages Lonza to scale manufacturing exosome based therapeutics Collaboration leverages RION’s proprietary biomanufacturing process to propel RION’s industry-leading clinical development pipeline towards late-phase trials and commercialisation for multiple regenerative medical conditions
  5. Developing strategies for robust chemistry, manufacturing and controls execution for advanced biologics Chemistry, manufacturing and controls (CMC) is a fundamental discipline for complex drug development projects. It must be rigorously implemented to navigate stringent regulatory requirements before drug approval and commercialisation

Relevant companies

See more

Upcoming event

CPHI Frankfurt 2025

28–30 October 2025 | Exhibition | Frankfurt, Germany See all

You may also like

Manufacturing

Exploring Ireland’s thriving life sciences sector

NSF highlights its pivotal role in one of the world’s leading hubs for pharma and medical device manufacturing
Training & Education

Why you should use the three Cs systems approach to pharma remediation

When it comes to your remediation project, learn about the three key success factors that help assure a positive outcome
Regulatory

The foundations of pharmaceutical compliance for beginners

Whether you’re stepping into the pharmaceutical industry for the first time or pivoting into a compliance or quality assurance role after years of experience, mastering the fundamentals of quality and regulatory compliance is vital to your success—and to the success of your organisation
Regulatory

Why rigorous clinical evaluations matter: strategies to boost safety and compliance

This white paper provides a blueprint for achieving excellence in clinical evaluations through strategic enhancements
Regulatory

FDA US Agent Services, backed by former regulators and global expertise

If you need a trusted US Agent backed by regulatory experts, NSF can keep your US market entry on track
Manufacturing

Unlocking success: best practices for manufacturers under the FDA’s new LDT rule

For manufacturers selling LDTs in the United States, this represents a significant shift requiring careful attention and strategic planning to ensure compliance. This article distills insights from NSF experts Janet Book and Jacob Foster, who shared critical strategies for navigating this new regulatory environment in a recent webinar
Manufacturing

Common reasons why field certifiers fail accreditation

Biosafety cabinets are the backbone of laboratory safety; however, many facilities encounter significant obstacles when using them, such as high energy consumption, difficulties with decontamination and inefficient filter replacement processes
Subscribe now